Antioxidant interventions as novel preventive strategies for postoperative atrial fibrillation

International Journal of Cardiology

Volumn 145, Issue 1, 2010, Pages 140-142

  Liu, Tong ^a   Li, Guangping ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

NADPH oxidase inhibitors; Nitric oxide; Oxidative stress; Postoperative atrial fibrillation; Probucol; Thiazolidinediones

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLCYSTEINE; ALPHA TOCOPHEROL; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTIOXIDANT; ARGININE; ASCORBIC ACID; CARVEDILOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEVOSIMENDAN; NITROPRUSSIDE SODIUM; PIOGLITAZONE; PROBUCOL; ROSIGLITAZONE;

ANTIOXIDANT ACTIVITY; CLINICAL TRIAL; HEART ATRIUM FIBRILLATION; HUMAN; LETTER; OXIDATIVE STRESS; PATHOGENESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS;

EID: 78049473871     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.06.054     Document Type: Article

References (39)

1. D. Kaireviciute, A. Aidietis, and G.Y. Lip Atrial fibrillation following cardiac surgery: clinical features and preventative strategies Eur Heart J 30 2009 410 425
2. P. Korantzopoulos, T.M. Kolettis, D. Galaris, and J.A. Goudevenos The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation Int J Cardiol 115 2007 135 143
3. R. Rodrigo, J. Vinay, and R. Castillo Use of vitamins C and E as a prophylactic therapy to prevent postoperative atrial fibrillation Int J Cardiol 2009 10.1016/j.ijcard.2009.04.043
4. M.M. Elahi, S. Flatman, and B.M. Matata Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress-mediated myocardial injury phenomenon Eur J Cardiovasc Prev Rehabil 15 2008 735 741
5. T. Liu, L. Li, P. Korantzopoulos, E. Liu, and G. Li Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies Int J Cardiol 126 2008 160 170
6. W.L. Baker, M.W. Anglade, E.L. Baker, C.M. White, J. Kluger, and C.I. Coleman Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis Eur J Cardiothorac Surg 35 2009 521 527
7. S. Giannini, M. Serio, and A. Galli Pleiotropic effects of thiazolidinediones: taking a look beyond antidiabetic activity J Endocrinol Invest 27 2004 982 991
8. R. Da Ros, R. Assaloni, and A. Ceriello The preventive anti-oxidant action of thiazolidinediones: a new therapeutic prospect in diabetes and insulin resistance Diabet Med 21 2004 1249 1252
9. I. Villegas, A.R. Martin, W. Toma, and C.A. de la Lastra Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, protects against gastric ischemia-reperfusion damage in rats: role of oxygen free radicals generation Eur J Pharmacol 505 2004 195 203
10. J. Hwang, D.J. Kleinhenz, B. Lassegue, K.K. Griendling, S. Dikalov, and C.M. Hart Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production Am J Physiol Cell Physiol 288 2005 C899 905
11. M. Shimano, Y. Tsuji, and Y. Inden Pioglitazone, a peroxisome proliferator-activated receptor-gamma activator, attenuates atrial fibrosis and atrial fibrillation promotion in rabbits with congestive heart failure Heart Rhythm 5 2008 451 459
12. D. Xu, N. Murakoshi, and M. Igarashi The effects of PPAR-gamma activator on atrial fibrillation in aged rat model Heart Rhythm 6 2009 S172
13. P. Korantzopoulos, S. Kokkoris, E. Kountouris, I. Protopsaltis, K. Siogas, and A. Melidonis Regression of paroxysmal atrial fibrillation associated with thiazolidinedione therapy Int J Cardiol 125 2008 e51 3
14. P.D. Home, S.J. Pocock, and H. Beck-Nielsen Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial Lancet 373 2009 2125 2135
15. J.A. Dormandy, B. Charbonnel, and D.J. Eckland Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial Lancet 366 2005 1279 1289
16. M.W. Anglade, J. Kluger, C.M. White, J. Aberle, and C.I. Coleman Thiazolidinedione use and post-operative atrial fibrillation: a US nested case-control study Curr Med Res Opin 23 2007 2849 2855
17. T. Liu, P. Korantzopoulos, G. Li, and J. Li The potential role of thiazolidinediones in atrial fibrillation Int J Cardiol 128 2008 129 130
18. D.K. Singla, K. Kaur, A.K. Sharma, S. Dhingra, and P.K. Singal Probucol promotes endogenous antioxidant reserve and confers protection against reperfusion injury Can J Physiol Pharmacol 85 2007 439 443
19. K. Umeji, S. Umemoto, and S. Itoh Comparative effects of pitavastatin and probucol on oxidative stress, Cu/Zn superoxide dismutase, PPAR-gamma, and aortic stiffness in hypercholesterolemia Am J Physiol Heart Circ Physiol 291 2006 H2522 H2532
20. G. Li, L. Yin, and T. Liu Role of probucol in preventing contrast-induced acute kidney injury after coronary interventional procedure Am J Cardiol 103 2009 512 514
21. Y.T. Gong, W.M. Li, and Y. Li Probucol attenuates atrial autonomic remodeling in a canine model of atrial fibrillation produced by prolonged atrial pacing Chin Med J (Engl) 122 2009 74 82
22. Y. Li, L. Sheng, and W. Li Probucol attenuates atrial structural remodeling in prolonged pacing-induced atrial fibrillation in dogs Biochem Biophys Res Commun 381 2009 198 203
23. T. Liu, and G. Li Probucol and succinobucol in atrial fibrillation: pros and cons Int J Cardiol 2009 10.1016/j.ijcard.2009.02.026
24. J. Vinten-Johansen, Z.Q. Zhao, and M. Nakamura Nitric oxide and the vascular endothelium in myocardial ischemia-reperfusion injury Ann N Y Acad Sci 874 1999 354 370
25. U. Kiziltepe, B. Tunctan, and Z.B. Eyileten Efficiency of l-arginine enriched cardioplegia and non-cardioplegic reperfusion in ischemic hearts Int J Cardiol 97 2004 93 100
26. M.M. Elahi, M. Worner, J.S. Khan, and B.M. Matata Inspired nitric oxide and modulation of oxidative stress during cardiac surgery Curr Drug Saf 2009 [Electronic publication ahead of print]
27. R. Cavolli, K. Kaya, and A. Aslan Does sodium nitroprusside decrease the incidence of atrial fibrillation after myocardial revascularization? A pilot study Circulation 118 2008 476 481
28. S.V. Perrone, and E.J. Kaplinsky Calcium sensitizer agents: a new class of inotropic agents in the treatment of decompensated heart failure Int J Cardiol 103 2005 248 255
29. C. Avgeropoulou, I. Andreadou, and S. Markantonis-Kyroudis The Ca2+-sensitizer levosimendan improves oxidative damage, BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine Eur J Heart Fail 7 2005 882 887
30. J.T. Parissis, I. Andreadou, and S.L. Markantonis Effects of Levosimendan on circulating markers of oxidative and nitrosative stress in patients with advanced heart failure Atherosclerosis 195 2007 e210 5
31. S.G. De Hert, S. Lorsomradee, H. vanden Eede, S. Cromheecke, and P.J. Van der Linden A randomized trial evaluating different modalities of levosimendan administration in cardiac surgery patients with myocardial dysfunction J Cardiothorac Vasc Anesth 22 2008 699 705
32. T. Liu, G. Li, and G. Xu Levosimendan may prevent postoperative atrial fibrillation through anti-inflammatory and antioxidant modulation J Cardiothorac Vasc Anesth 2008 10.1053/j.jvca.2008.09.022
33. S. Selemidis, C.G. Sobey, K. Wingler, H.H. Schmidt, and G.R. Drummond NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition Pharmacol Ther 120 2008 254 291
34. S.C. Dudley Jr., N.E. Hoch, and L.A. McCann Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases Circulation 112 2005 1266 1273
35. Y.M. Kim, T.J. Guzik, and Y.H. Zhang A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation Circ Res 97 2005 629 636
36. Y.M. Kim, H. Kattach, C. Ratnatunga, R. Pillai, K.M. Channon, and B. Casadei Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery J Am Coll Cardiol 51 2008 68 74
37. H.C. Williams, and K.K. Griendling NADPH oxidase inhibitors: new antihypertensive agents? J Cardiovasc Pharmacol 50 2007 9 16
38. A.A. Sovari, N. Morita, and H.S. Karagueuzian Apocynin: a potent NADPH oxidase inhibitor for the management of atrial fibrillation Redox Rep 13 2008 242 245
39. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150